Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00007540 | Study of Prostate Cancer in Black and White U.S. Veterans | completed | — | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00018538 | Calcifidol Therapy in Men With Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00018551 |
| Chemoprevention With Folic Acid |
| completed |
| Phase 2 |
| — |
| US Department of Veterans AffairsFED |
| 1 |
| Jan 21, 2009 |
| clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00116610 | Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | completed | Phase 2 | 75 | Poniard PharmaceuticalsINDUSTRY | 3 | Jan 21, 2009 | clinicaltrials |
| NCT00216801 | Relationship of Ochratoxin A to Upper Urologic Cancers | completed | — | 60 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00826033 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer | completed | — | — | Gunma UniversityOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00167648 | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer(NE2) | completed | Phase 2 | 17 | University of WashingtonOTHER | 1 | Jan 19, 2009 | clinicaltrials |
| NCT00364624 | Adrenal Function in Patients With Newly Diagnosed Lung Cancer | completed | — | 133 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Jan 16, 2009 | clinicaltrials |
| NCT00581880 | Measuring Hope and Hopelessness in Cancer | completed | — | 288 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 15, 2009 | clinicaltrials |
| NCT00142532 | Acupuncture for Post-Thoracotomy Pain | completed | Phase 3 | 162 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00496301 | Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC(SOGUG-02-06) | completed | Phase 2 | 40 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00533533 | A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer(DO for AGC) | completed | Phase 1 / Phase 2 | 68 | Samsung Medical CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00049790 | Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer | completed | Phase 2 | — | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00222027 | Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial(GRAALL2003) | completed | Phase 2 | 300 | University Hospital, ToulouseOTHER | 1 | Jan 7, 2009 | clinicaltrials |
| NCT00579917 | Behavioral Intervention For BMT/SCT Survivors(BMT/SCT) | completed | — | 133 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 7, 2009 | clinicaltrials |
| NCT00809484 | Arimidex Bone Mass Index and Oral Bisphosphonates(ARBI) | completed | — | 220 | Hellenic Breast Surgeons SocietyOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | completed | — | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00108134 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | completed | Phase 2 | 60 | PeplinINDUSTRY | 1 | Dec 24, 2008 | clinicaltrials |
| NCT00131898 | A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma | completed | Phase 3 | 150 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 23, 2008 | clinicaltrials |
| NCT00290953 | Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide(SESAME) | completed | Phase 2 / Phase 3 | 432 | SanofiINDUSTRY | 14 | Dec 23, 2008 | clinicaltrials |
| NCT00812942 | Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy | completed | N/A | 9,889 | Istituto Superiore di SanitàOTHER | 1 | Dec 22, 2008 | clinicaltrials |
| NCT00444782 | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | completed | Phase 2 | 41 | Pharmexa A/SINDUSTRY | 3 | Dec 18, 2008 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 | clinicaltrials |
| NCT00157703 | G207 Followed by Radiation Therapy in Malignant Glioma | completed | Phase 1 | 9 | MediGeneINDUSTRY | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00463073 | Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas | completed | Phase 2 | 32 | Rigshospitalet, DenmarkOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00806728 | Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease | completed | Phase 1 | 17 | MedImmune LLCINDUSTRY | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00306618 | Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma | completed | Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Dec 10, 2008 | clinicaltrials |
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 86 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00088101 | STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors | completed | Phase 1 | 42 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00511498 | Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy | completed | N/A | 100 | Johns Hopkins UniversityOTHER | 1 | Dec 1, 2008 | clinicaltrials |
| NCT00390897 | Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia | completed | Phase 4 | 360 | PETHEMA FoundationOTHER | 1 | Nov 27, 2008 | clinicaltrials |
| NCT00560053 | Pethema Multiple Myeloma 2000 | completed | Phase 3 | 500 | PETHEMA FoundationOTHER | 0 | Nov 27, 2008 | clinicaltrials |
| NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 76 | NSABP Foundation IncNETWORK | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00188591 | Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00394810 | Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 21 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00400348 | Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer | completed | Phase 2 | 18 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00481455 | Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM) | completed | Phase 2 | 15 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00511069 | Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia | completed | Phase 2 | 3 | University of BolognaOTHER | 1 | Nov 24, 2008 | clinicaltrials |
| NCT00336531 | Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation | completed | Phase 4 | 100 | Samsung Medical CenterOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00388895 | Glivec in Ph Positive Lymphoblastic Leukemia | completed | Phase 2 | 35 | PETHEMA FoundationOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00487448 | SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia(FLAG-IDA) | completed | Phase 4 | 200 | PETHEMA FoundationOTHER | 1 | Nov 19, 2008 | clinicaltrials |
| NCT00458250 | Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H | completed | Phase 1 | 10 | Tehran University of Medical SciencesOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00488709 | Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia(FLAT) | completed | Phase 4 | 47 | PETHEMA FoundationOTHER | 1 | Nov 18, 2008 | clinicaltrials |
| NCT00792285 | RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening | completed | N/A | 80,000 | Harvard Pilgrim Health CareOTHER | 1 | Nov 17, 2008 | clinicaltrials |
| NCT00130195 | Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) | completed | Phase 2 | 100 | Japan Adult Leukemia Study GroupOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00198250 | Venlafaxine for Hot Flashes After Breast Cancer | completed | Phase 2 | 75 | Indiana UniversityOTHER | 1 | Nov 14, 2008 | clinicaltrials |
Data updated 24 days agoSource updated Jan 21, 2009source: clinicaltrials